Mahesh V. Patel insider trades: Lipocine (LPCN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mahesh reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | LPCN | ↑ Buy | 25,000 | $2.03 | $51K | Direct | Apr 6, 2026 (0d) |
| Apr 2, 2026 | LPCN | ↑ Buy | 25,000 | $2.02 | $51K | Direct | Apr 2, 2026 (0d) |
| May 25, 2023 | LPCN | ↑ Buy | 8,706 | $5.03 | $44K | Direct | May 25, 2023 (0d) |
| Mar 24, 2023 | LPCN | ↑ Buy | 150,000 | $0.32 | $48K | Direct | Mar 24, 2023 (0d) |
| Mar 17, 2023 | LPCN | ↑ Buy | 50,000 | $0.33 | $17K | Direct | Mar 17, 2023 (0d) |
| Nov 14, 2022 | LPCN | ↑ Buy | 75,000 | $0.39 | $29K | Direct | Nov 14, 2022 (0d) |
| Sep 27, 2022 | LPCN | ↑ Buy | 100,000 | $0.41 | $41K | Direct | Sep 27, 2022 (0d) |
| May 16, 2022 | LPCN | ↑ Buy | 50,000 | $0.77 | $38K | Direct | May 16, 2022 (0d) |
| Nov 18, 2021 | LPCN | ↑ Buy | 25,000 | $1.09 | $27K | Direct | Nov 18, 2021 (0d) |
| Dec 16, 2020 | LPCN | ↓ Sell10b5-1 | 15,000 | $1.35 | $20K | Direct | Dec 17, 2020 (1d) |
| Dec 4, 2020 | LPCN | ↓ Sell10b5-1 | 43,500 | $1.57 | $68K | Direct | Dec 8, 2020 (4d) |
| Dec 31, 2019 | LPCN | ↑ Buy | 40,000 | $0.38 | $15K | Direct | Jan 2, 2020 (2d) |
| Dec 10, 2019 | LPCN | ↑ Buy | 25,000 | $0.40 | $10K | Direct | Dec 10, 2019 (0d) |
| Dec 4, 2019 | LPCN | ↓ Sell10b5-1 | 43,500 | $0.41 | $18K | Direct | Dec 6, 2019 (2d) |
| Nov 26, 2019 | LPCN | ↑ Buy | 25,000 | $0.43 | $11K | Direct | Nov 26, 2019 (0d) |
| Nov 18, 2019 | LPCN | ↑ Buy | 50,000 | $0.40 | $20K | Direct | Nov 18, 2019 (0d) |
| Dec 29, 2017 | LPCN | ↓ Sell10b5-1 | 6,000 | $3.48 | $21K | Direct | Jan 2, 2018 (4d) |
| Sep 30, 2015 | LPCN | ↑ Buy | 4,000 | $11.84 | $47K | Direct | Oct 2, 2015 (2d) |
| Nov 25, 2014 | LPCN | ↑ Buy | 2,000 | $5.10 | $10K | Direct | Nov 25, 2014 (0d) |
| Nov 24, 2014 | LPCN | ↑ Buy | 2,000 | $5.45 | $11K | Direct | Nov 24, 2014 (0d) |
| Nov 14, 2014 | LPCN | ↑ Buy | 2,000 | $5.06 | $10K | Direct | Nov 14, 2014 (0d) |
| Nov 13, 2014 | LPCN | ↑ Buy | 2,000 | $5.05 | $10K | Direct | Nov 13, 2014 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LPCN insiders
Open-market trades in the last 12 months
About Mahesh V. Patel's insider trades
Mahesh V. Patel is Chief Executive Officer at Lipocine (LPCN). Since Nov 13, 2014, Mahesh has reported 18 open-market purchases worth $490K and 4 sales worth $127K on SEC Form 4. In the last 12 months: 2 buys ($101K).
4 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (22 filings), option exercises (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LPCN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.